|
In the third poster, views of patients and doctors regarding predominant negative symptoms were compared during a 1 - year observational study. The final poster was providing information on the ...
Adnkronos
-
15-4-2024
|
|
|
|
In addition, PCCT's heightened sensitivity and precision in photon counting provide improved imaging with less radiation exposure, minimizing radiation risks faced by patients. PCCT also excels in ...
Adnkronos
-
13-4-2024
|
|
|
|
Modalis is the pioneer and leader in CRISPR - based epigenome modulation technology, developing therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS, ...
01Net
-
12-4-2024
|
|
|
|
In our ongoing RESPONDER - HF trial we are excluding those patients and using exercise hemodynamics to qualify and randomize HFpEF patients most likely to respond favorably to shunting." "In this ...
Adnkronos
-
12-4-2024
|
|
|
|
... address clinical issues as they occur, prioritize patients at highest risk, and improve outcomes.' Contributing to AAPACN's educational agenda, Real Time's Michele Self , Clinical Account Specialist,...
01Net
-
11-4-2024
|
|
|
|
Key Findings from the Study: A 76% reduction in the likelihood of hospital readmission within six months for patients using telemedicine. A 41% decrease in the likelihood of attending the emergency ...
01Net
-
11-4-2024
|
|
|
|
Traumasoft's mission - critical EMS software platform is trusted by nearly 200 customers to deliver better outcomes for patients while optimizing operational processes. Serent's growth capital and ...
01Net
-
10-4-2024
|
|
|
|
... billing and management under one cohesive remote care strategy.' 'With Dexcom's continuous glucose monitoring systems, patients have the awareness they need to manage glucose levels more closely ...
01Net
-
10-4-2024
|
|
|
|
'Our business relies on meeting our patients' and communities' needs - whenever those needs arise. We pride ourselves on delivering consistent, positive experiences no matter what site or variety of ...
01Net
-
10-4-2024
|
|
|
|
"Since its launch, a total of 1.3 million patients were treated with cariprazine and it was the 46th best - selling innovative medicine in 2023, with sales of nearly $3 billion and a real chance of ...
Adnkronos
-
10-4-2024
|
|
|
